125/DPI (Estropipate 1.5 mg)
Pill imprint 125/DPI has been identified as Estropipate 1.5 mg.
Estropipate is used in the treatment of atrophic vaginitis; hypoestrogenism; postmenopausal symptoms; osteoporosis; primary ovarian failure (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 125/DPI
- Strength:
- 1.5 mg
- Availability:
- Prescription only
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
More about estropipate
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: estrogens
Consumer resources
Other brands: Ogen, Ortho-Est, Ogen 2.5, Ogen 1.25, Ogen 0.625
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
